Question

22. My friend, Marina, is keeping her HER+ cancer from growing by using Herceptin that is attached to a cytotoxic, antineoplastic drug. Thus, where Herceptin alone was not working, she is now successfully using Herceptin ______________.

a. in a conjugated monoclonal antibody form.

b. to deliver PD-1 inhibitors to each cancer cell.

c. to target all actively dividing cells.

d. to unleash cytotoxic T cells.

Answer 1

a) in a conjugated monoclonal antibody​ form

Herceptin is a monoclonal body when it is attached to a cytotoxic antineoplastic drug it is called conjugated monoclonal antibody..